Sign up United Kingdom
Proactive Investors - Run By Investors For Investors

InnovaDerma remains confident in spite of Superdrug decision

Sales growth for the year overall will still be significantly ahead of the first half’s 31% (to £4.2mln), and last year’s total of £8.9mln, but less than previously expected
Skinny Tan is a pre-holiday alternative

InnovaDerma PLC (LON:IDP) has trimmed this year’s sales and profits expectations after Superdrug reduced orders of Skinny Tan, its fast-growing tanning product.

Sales growth for the year overall will still be significantly ahead of the first half’s 31% (to £4.2mln), and last year’s total of £8.9mln but less than previously expected.

READ: InnovaDerma confident of strong second half as sales of Roots product line pick up strongly

Annual profits will also be flat at about £1mln.

Superdrug was the largest retail outlet for Skinny Tan, with sales running at 13,000 tubes per month at one point and the brand becoming the chemist chain’s best-seller in its category.

Haris Choudry, executive chairman, said: "Whilst we expect our full-year results to be below our earlier expectations, InnovaDerma continues to perform strongly and profitably.

“Our online engagement continues to grow daily which is driving revenue through to our DTC (direct-to-consumer) platforms.

“We are in discussions with several new retail distributors and product innovation remains on track.

“The business remains robust with several product and market launches expected in the coming months to generate further growth."

Direct sales still doing well

Independent data group IRI estimates Superdrug’s Skinny Tan's revenue (including sub-brand Body Glow) grew by 210% for the 52 weeks to 24 February but by 60% in the last 12 weeks of the period.

Direct sales are still going well, said the company, which is looking for new distributors for the product.

New hair care range Roots is also powering ahead with sales 254% higher in the 12 weeks to February.

View full IDP profile View Profile

InnovaDerma PLC Timeline

Related Articles

March 08 2018
“InnovaDerma continues to perform strongly and profitably”

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use